CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Sanhe Bio-tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Sanhe Bio-tech Co Ltd
No.300 East Jingxing Road
Shuangta Neighbourhood, Jiangshan City
Phone: +86 5704965558p:+86 5704965558 QUZHOU, ZHJ  324123  China Fax: +86 5704692558f:+86 5704692558

Business Summary
Zhejiang Sanhe Bio-tech Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of functional red yeast rice. Its products are used in the fields of medicine, food, health care and cosmetics. The Company mainly operates its businesses in China, European Union countries, the United States and Southeast Asian countries.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201412/31/2014Yes----

Industries
SIC Code Description
2099 Food preparations, not elsewhere classified

General Information
Outstanding Shares: 8,000,000 (As of 12/31/2014)
Fax Number: +86 5704692558


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023